(Poster): Preclinical findings support the development of PYC-001
PYC-001, a peptide-conjugated phosphorodiamidate
morpholino oligomer for the treatment of autosomal
dominant optic atrophy
https://pyctx.com/wp-content/uploads/2023/05/20230424_ADOA-TIDES-Poster_FINAL-A4.pdf
preclinical peptide-#Morpholino (PPMO)